This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Johns Hopkins University. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: InYoung Choi: Innovator in Stem Cell Research
Introduction
InYoung Choi is a prominent inventor based in Baltimore, MD (US), known for his contributions to the field of stem cell research. With a total of 2 patents, he has made significant strides in utilizing optogenetics for advancing stem cell technology.
Latest Patents
Choi's latest patents include groundbreaking inventions that focus on enhancing the capabilities of stem cells. One of his notable patents is titled "Optically controllable FGFR stimulation using wireless controlled cellular lighting system." This invention provides compositions and methods for using optogenetics to sustain the pluripotency of stem cells. It involves a vector that comprises a nucleotide sequencing encoding a fusion protein, which includes the intracellular domain of fibroblast growth factor 1 receptor (FGFR1) and a photoactivatable domain. Another significant patent is "Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy." This patent describes methods for isolating high purity myoblasts that are essential for creating novel DMD model systems and therapeutic methods based on the use of these myoblasts.
Career Highlights
InYoung Choi is affiliated with The Johns Hopkins University, where he conducts his research and development in stem cell technology. His work has garnered attention for its innovative approach to addressing challenges in the field of regenerative medicine.
Collaborations
Choi collaborates with esteemed colleagues, including Gabsang Lee and HoTae Lim, who contribute to his research endeavors and enhance the impact of his inventions.
Conclusion
InYoung Choi's innovative work in stem cell research exemplifies the potential of optogenetics in advancing medical science. His patents reflect a commitment to improving therapeutic applications and understanding stem cell biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
